BROWSE·page 2 of 12

Browse EX-10 agreements

137 matching material contract exhibits.


EX-10.4

Glucotrack, Inc.

** **

Exhibit 10.4

** **

COMMON STOCK PURCHASE AGREEMENT

** **

This Common Stock Purchase Agreement (this “Agreement”) is dated as of July 14, 2026 (the “Effective Date”), by and between Glucotrack, Inc., a Delaware corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).

WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall purchase, from time to time, as provided herein, and the Company shall issue and sell up to Fifty Million Dollars ($50,000,000) of the Company’s Common Stock (as defined below);

EX-10.4·425·CIK 1506983·ACC 0001493152-26-033395·Filed Jul 15, 2026, 17:20 ET

EX-10.2

Glucotrack, Inc.

SECURITY AGREEMENT

This SECURITY AGREEMENT, dated as of July 14, 2026 (this “Agreement”), is among Glucotrack, Inc., a Delaware corporation (the “Company” or the “Debtor”), White Lion Capital LLC, a Delaware limited liability company, as collateral agent for the Secured Parties (in such capacity, the “Collateral Agent”), and the investors named herein, (collectively with their respective endorsees, transferees and assigns, the “Secured Parties”).

W I T N E S S E T H:

WHEREAS, pursuant to the securities purchase agreement entered into by the Company and the Secured Parties on or around July 14, 2026 (the “Purchase Agreement”), the Secured Parties have agreed to extend the loan to Company as evidenced by those certain senior secured convertible promissory notes dated on or around July 14, 2026, in the original aggregate principal amount of up to $5,705,128.10 (collectively, the “Note”);

EX-10.2·425·CIK 1506983·ACC 0001493152-26-033395·Filed Jul 15, 2026, 17:20 ET

EXHIBIT 10.1

TRICO BANCSHARES /

COMPANY VOTING AND SUPPORT AGREEMENT

July 12, 2026

First Hawaiian, Inc.
999 Bishop St., 29th Floor
Honolulu, Hawaii 96813

Ladies and Gentlemen:

As a holder of shares of common stock of TriCo Bancshares, a California corporation (the “Company” and such common stock, the “Company Common Stock”), the undersigned (the “Shareholder”) understands that the Company, First Hawaiian, Inc., a Delaware corporation (“Parent”), and Horizon Merger Sub, Inc., a California corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), are concurrently entering into that certain Agreement and Plan of Reorganization and Merger, dated as of the date of this voting and support agreement (this “Agreement” and, such Agreement and Plan of Reorganization and Merger, as it may be amended, modified or supplemented from time to time in accordance with its terms, the “Merger Agreement”), pursuant to which, among other things and subject to the terms and conditions set forth in the Merger Agreement, (i) Merger Sub will merge with and into the Company (the “Merger”), with the Company

EX-10.1·425·CIK 356171·ACC 0001104659-26-083899·Filed Jul 15, 2026, 16:25 ET

EXHIBIT 10.1

Twin Vee PowerCats, Co.

Consulting Agreement

CONSULTING AGREEMENT

This Consulting Agreement (“Agreement”) is entered into as of February 25, 2026 by and between:

Consultant: Michael P. Dickerson, 416 NW Canterbury Ct, Port St. Lucie, FL, 34983 and/or Dickerson Financial Services, LLC, 416 NW Canterbury Ct. Port St. Lucie, FL 34983.

Company: Twin Vee PowerCats Co., 3101 S. US Hwy. 1, Ft. Pierce Fl, 34982

1. Services and Compensation

1.1 Consultant agrees to provide advisory, financial, strategic, or other professional services (“Services”) as requested and authorized by the Company from time to time. The Services shall include:

1.1(a): Preparation of quarterly filings on Form 10-Q

1.1(b): Preparation of annual report on Form 10-K

1.1(c): Assist CFO/company with documentation and determination of significant accounting policies/decisions;

1.1(d): Preparation of supporting information for Twin Vee tax return;

1.1(e): Preparation of supporting information for Visconti Enterprises tax return;

EX-10.1·425·CIK 1855509·ACC 0001731122-26-000941·Filed Jul 14, 2026, 20:50 ET

EXHIBIT 10.2

NextCure, Inc.

Exhibit 10.2

Final Form

PARENT SUPPORT AGREEMENT

This Support Agreement (this “Agreement”) is made and entered into as of July 14, 2026, by and among Avere Therapeutics, Inc., a Delaware corporation (the “Company”), NextCure, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder of Parent (the “Stockholder” and each of the Stockholder, Company, and Parent, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

RECITALS

EX-10.2·425·CIK 1661059·ACC 0001104659-26-083327·Filed Jul 14, 2026, 07:02 ET

EXHIBIT 10.5

NextCure, Inc.


Exhibit 10.5

Final Form

LOCK-UP AGREEMENT

July 14, 2026

NextCure, Inc.

9000 Virginia Manor Road, Suite 200

Beltsville, MD 20705

Attention: [•]

Email: [•]

Ladies and Gentlemen:

The undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that NextCure, Inc., a Delaware corporation (“Parent”), has entered into an Agreement and Plan of Merger and Reorganization, dated as of July 14, 2026 (as the same may be amended from time to time, the “Merger Agreement”) with Neptune Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of Parent, Neptune Second Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent, and Avere Therapeutics, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement.

| | |

EX-10.5·425·CIK 1661059·ACC 0001104659-26-083327·Filed Jul 14, 2026, 07:02 ET

EXHIBIT 10.3

NextCure, Inc.

Final Form

SECURITIES PURCHASE AGREEMENT

This SEC****URITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of [•], 2026, by and among Avere Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the “Securities Act”);

EX-10.3·425·CIK 1661059·ACC 0001104659-26-083327·Filed Jul 14, 2026, 07:02 ET

EXHIBIT 10.6

NextCure, Inc.

Exhibit 10.6

Final Form

CONTINGENT VALUE RIGHTS AGREEMENT

This **CONTINGENT VALUE RIGHTS AGREEMENT **(this “Agreement”), dated as of [●], is entered into by and between NextCure, Inc., a Delaware corporation (the “Company”), and [●], a [●], as the Rights Agent (as defined herein), and [●], a [●], solely in its capacity as the initial representative, agent and attorney in fact of the Holders (the “Representative”).

RECITALS

EX-10.6·425·CIK 1661059·ACC 0001104659-26-083327·Filed Jul 14, 2026, 07:02 ET

EXHIBIT 10.1

NextCure, Inc.

Exhibit 10.1

Final Form

COMPANY SUPPORT AGREEMENT

This Support Agreement (this “Agreement”) is made and entered into as of July 14, 2026, by and among Avere Therapeutics, Inc., a Delaware corporation (the “Company”), NextCure, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder of the Company (the “Stockholder” and each of the Stockholder, Company, and Parent, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

RECITALS

EX-10.1·425·CIK 1661059·ACC 0001104659-26-083327·Filed Jul 14, 2026, 07:02 ET

EXHIBIT 10.4

NextCure, Inc.

Exhibit 10.4

Final Form

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [•], 2026, is entered into by and among Avere Therapeutics, Inc., a Delaware corporation (the “Company”) and the several investors signatory hereto (individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the Company and the Investors party thereto, dated as of [•], 2026 (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

EX-10.4·425·CIK 1661059·ACC 0001104659-26-083327·Filed Jul 14, 2026, 07:02 ET

LOAN AGREEMENT, DATED JULY 9, 2026

Chicago Atlantic Real Estate Finance, Inc.

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

LOAN AND SECURITY AGREEMENT

** **

THIS LOAN AND SECURITY AGREEMENT is dated as of July 9, 2026 (the “Closing Date”), and is among KOACH [NAME] LLC, a Michigan limited liability company (“Borrower”), each Person party hereto as a Guarantor (as defined below) from time to time, the creditors which are now or which hereafter become a party hereto (collectively, “Lenders” and each, a “Lender”), and CHICAGO ATLANTIC FINANCIAL SERVICES, LLC (“Chicago Atlantic”), as Administrative Agent.

recitals

WHEREAS, Borrower has asked Lenders to extend a term loan facility to Borrower; and

WHEREAS, subject to and upon the terms and conditions herein set forth, each Lender is willing to provide such financing to Borrower;

EX-10.1·425·CIK 1867949·ACC 0001213900-26-077598·Filed Jul 13, 2026, 16:31 ET

FORM OF LOCK-UP LETTER

Chicago Atlantic Real Estate Finance, Inc.

** **

___________, 2026

** **

Chicago Atlantic Real Estate Finance, Inc.

1680 Michigan Avenue, Suite 700

Miami Beach, Florida 33139

Re: Chicago Atlantic Real Estate Finance, Inc. - Subscription Lock-up

Dear Sir or Madam:

EX-10.2·425·CIK 1867949·ACC 0001213900-26-077598·Filed Jul 13, 2026, 16:31 ET